A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

Completed · Phase 4

Conditions studied: Obesity

In brief

The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Key facts

Study ID

NCT01035333

Run by

Albany College of Pharmacy and Health Sciences

People needed

19

Starts

2009-11-01

Expected to finish

2011-04-01

Last updated by the study team

2014-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients preparing for gastric bypass surgery

You may not qualify if…

• pregnancy

Where it is running

• Albany College of Pharmacy and Health Sciences — Albany, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.